Navidea Biopharmaceuticals Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
32,939.00
5,479.00
7,166.30
6,540.60
4,592.60
4,275.20
Total Accounts Receivable
1,150.60
816.50
3,703.20
203.00
8,137.90
21.20
Inventories
2,232.40
932.40
652.90
96.20
-
-
Other Current Assets
1,009.10
1,371.20
1,054.80
3,986.50
1,101.90
1,299.50
Total Current Assets
37,331.20
8,599.10
12,577.20
10,826.30
13,832.40
5,595.80
Net Property, Plant & Equipment
2,125.40
2,509.70
1,927.60
1,180.60
236.70
162.20
Total Investments and Advances
-
241.60
-
-
-
-
Long-Term Note Receivable
-
-
-
-
4,809.40
-
Intangible Assets
136.90
180.80
186.20
146.70
458.20
428.50
Other Assets
723.10
388.90
273.60
308.10
1,444.80
835.10
Total Assets
40,316.50
11,920.20
14,964.50
12,461.70
20,781.40
7,021.50
ST Debt & Current Portion LT Debt
4,095.70
4,383.50
333.30
51,957.90
2,353.60
Accounts Payable
2,422.30
1,477.50
1,767.50
5,165.40
855.00
Other Current Liabilities
4,773.00
3,234.10
4,083.00
12,738.50
4,859.70
Total Current Liabilities
11,291.00
9,095.10
6,183.90
69,861.80
8,068.40
Long-Term Debt
23,572.60
29,539.10
60,746.00
9,641.20
-
Other Liabilities
9,462.50
3,089.40
1,870.40
624.90
664.70
Total Liabilities
44,326.10
41,723.60
68,800.20
80,127.90
8,733.10
Common Equity (Total)
4,009.60
29,803.50
54,305.30
68,135.10
11,379.60
Total Shareholders' Equity
4,009.60
29,803.50
54,305.30
68,135.10
11,379.60
Total Equity
4,009.60
29,803.50
53,835.70
67,666.20
12,048.30
Liabilities & Shareholders' Equity
40,316.50
11,920.20
14,964.50
12,461.70
20,781.40
Accumulated Minority Interest
-
-
469.60
468.90
668.70
Preferred Stock (Carrying Value)
0.00
0.00
-
-
-
About Navidea Biopharmaceuticals
View Profile
